Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Lipid Research|July 20, 2004
Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodiesGabriel Virella, Suzanne R Thorpe, Nathan L Alderson, et al.
The Journal of Biological Chemistry|March 16, 2007
Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH ceramides during keratinocyte differentiationYoshikazu Uchida, Hiroko Hama, Nathan L Alderson, et al.
Kidney International|May 20, 2003
The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese ratsNathan L Alderson, Mark E Chachich, Nancy N Youssef, et al.
Archives of Biochemistry and Biophysics|April 28, 2004
Chemical modification of muscle protein in diabetesNadja Alt, James A Carson, Nathan L Alderson, et al.
The Journal of Biological Chemistry|August 13, 2008
Regulation of telomere length by fatty acid elongase 3 in yeast. Involvement of inositol phosphate metabolism and Ku70/80 functionSuriyan Ponnusamy, Nathan L Alderson, Hiroko Hama, et al.
Metabolism: Clinical and Experimental|July 29, 2004
In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetesAlicia J Jenkins, Suzanne R Thorpe, Nathan L Alderson, et al.
Kidney International|February 19, 2002
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic ratThorsten P Degenhardt, Nathan L Alderson, David D Arrington, et al.
Archives of Biochemistry and Biophysics|April 21, 2006
S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediateNathan L Alderson, Yuping Wang, Matthew Blatnik, et al.
Diabetes|August 28, 2002
The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetesAlan Stitt, Thomas A Gardiner, Nathan L Alderson, et al.
Physiological Genomics|December 18, 2003
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate agingHolly Van Remmen, Yuji Ikeno, Michelle Hamilton, et al.
Pageof 3